Multi-center Application of Bivalirudin in Left Atrial Appendage Occlusion
NCT04195997
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Evaluate the Safety and Efficacy of Bivalirudin in Decreasing Bleeding Risk
Interventions
DRUG:
Bivalirudin
DRUG:
Heparin
Sponsor
Shanghai Zhongshan Hospital